We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Astellas and Boehringer Ingelheim have filed a patent infringement suit against Impax Laboratories for submitting an ANDA to market a generic version of Flomax capsules, 0.4 mg, a treatment for benign prostatic hyperplasia.